News from presage biosciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 02, 2021, 07:00 ET Presage Sets the Stage for Commercial Expansion with Closing of $13M Financing and Execution of New Phase 0 Trial Agreements with Merck and Maverick Therapeutics

Presage Biosciences, Inc., a biotechnology company pioneering a new cancer drug development approach using its Comparative In Vivo Oncology (CIVO®)...

Sep 09, 2020, 07:00 ET Presage Announces New, Multi-Project Collaboration with Takeda for Phase 0 Studies of Novel Cancer Agents with CIVO® Technology

Presage Biosciences, a biotechnology company pioneering a new cancer drug development approach using its Comparative In Vivo Oncology (CIVO®)...

Jan 09, 2020, 08:00 ET Presage Receives FDA Clearance of First IND Application for Trial to Evaluate Investigational Oncology Agents with CIVO™ Technology

Presage Biosciences, a biotechnology company pioneering a new cancer drug development approach using its CIVO® intratumoral microdosing platform,...

Aug 27, 2019, 08:00 ET Presage Announces Collaboration with Bristol-Myers Squibb for Phase O Studies of Novel Cancer Agents Utilizing CIVO™ Technology

Presage Biosciences, a cancer biotechnology company pioneering a new cancer drug development approach using its CIVO™ multiplexed intratumoral...

May 02, 2019, 08:00 ET Presage Announces Collaboration with Celgene to Investigate Novel Agents with CIVO™ Technology

Presage Biosciences, a cancer biotechnology company pioneering a new cancer drug development approach using its CIVO™ intratumoral microdosing...

Jul 17, 2018, 08:00 ET Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer

Presage Biosciences, a cancer biotechnology company pioneering the use of intratumoral microdosing for Phase 0 investigation of early development...

Apr 19, 2013, 08:00 ET Presage Biosciences Announces First Patient in Clinical Trial of CIVO™ Precision Oncology

Presage Biosciences, a leader in precision oncology, today announced the initiation of a clinical trial and the first patient use of CIVO™, the...

Mar 05, 2013, 08:00 ET Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation

Presage Biosciences, a leader in discovering effective cancer drug combinations, today announced that it has entered into a strategic collaboration...